| Calreticulin exposure dictates the immunogenicity of cancer cell death M Obeid, A Tesniere, F Ghiringhelli, GM Fimia, L Apetoh, JL Perfettini, ... Nature medicine 13 (1), 54-61, 2007 | 3217 | 2007 |
| Inhibition of macroautophagy triggers apoptosis P Boya, RA González-Polo, N Casares, JL Perfettini, P Dessen, ... Molecular and cellular biology 25 (3), 1025-1040, 2005 | 2020 | 2005 |
| Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death N Casares, MO Pequignot, A Tesniere, F Ghiringhelli, S Roux, N Chaput, ... The Journal of experimental medicine 202 (12), 1691-1701, 2005 | 1567 | 2005 |
| AIF deficiency compromises oxidative phosphorylation N Vahsen, C Candé, JJ Brière, P Bénit, N Joza, N Larochette, ... The EMBO journal 23 (23), 4679-4689, 2004 | 729 | 2004 |
| A novel dendritic cell subset involved in tumor immunosurveillance J Taieb, N Chaput, C Ménard, L Apetoh, E Ullrich, M Bonmort, ... Nature medicine 12 (2), 214-219, 2006 | 534 | 2006 |
| Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy Y Ma, L Aymeric, C Locher, SR Mattarollo, NF Delahaye, P Pereira, ... Journal of Experimental Medicine 208 (3), 491-503, 2011 | 389 | 2011 |
| CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-γ-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by … N Casares, L Arribillaga, P Sarobe, J Dotor, A Lopez-Diaz de Cerio, ... The Journal of Immunology 171 (11), 5931-5939, 2003 | 255 | 2003 |
| Apoptosis regulation in tetraploid cancer cells M Castedo, A Coquelle, S Vivet, I Vitale, A Kauffmann, P Dessen, ... The EMBO journal 25 (11), 2584-2595, 2006 | 232 | 2006 |
| Abnormal Priming of CD4+ T Cells by Dendritic Cells Expressing Hepatitis C Virus Core and E1 Proteins P Sarobe, JJ Lasarte, N Casares, A López-Díaz de Cerio, E Baixeras, ... Journal of virology 76 (10), 5062-5070, 2002 | 223 | 2002 |
| Immune response against dying tumor cells L Zitvogel, N Casares, MO Péquignot, N Chaput, ML Albert, G Kroemer Advances in immunology 84, 131-180, 2004 | 197 | 2004 |
| Upregulation of indoleamine 2, 3-dioxygenase in hepatitis C virus infection E Larrea, JI Riezu-Boj, L Gil-Guerrero, N Casares, R Aldabe, P Sarobe, ... Journal of virology 81 (7), 3662-3666, 2007 | 152 | 2007 |
| Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression C Segovia, E San Jose-Eneriz, E Munera-Maravilla, ... Nature medicine 25 (7), 1073-1081, 2019 | 144 | 2019 |
| Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies E San José-Enériz, X Agirre, O Rabal, A Vilas-Zornoza, JA Sanchez-Arias, ... Nature communications 8 (1), 15424, 2017 | 140 | 2017 |
| A peptide inhibitor of FOXP3 impairs regulatory T cell activity and improves vaccine efficacy in mice N Casares, F Rudilla, L Arribillaga, D Llopiz, JI Riezu-Boj, T Lozano, ... The Journal of Immunology 185 (9), 5150-5159, 2010 | 128 | 2010 |
| The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo JJ Lasarte, N Casares, M Gorraiz, S Hervás-Stubbs, L Arribillaga, ... The Journal of Immunology 178 (2), 748-756, 2007 | 126 | 2007 |
| Expansion of Tumor-Infiltrating CD8+ T cells Expressing PD-1 Improves the Efficacy of Adoptive T-cell Therapy SM Fernandez-Poma, D Salas-Benito, T Lozano, N Casares, JI Riezu-Boj, ... Cancer research 77 (13), 3672-3684, 2017 | 116 | 2017 |
| Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C JJ Lasarte, M García-Granero, A López, N Casares, N García, MP Civeira, ... Hepatology 28 (3), 815-822, 1998 | 105 | 1998 |
| Immunization with a tumor‐associated CTL epitope plus a tumor‐related or unrelated Th1 helper peptide elicits protective CTL immunity N Casares, JJ Lasarte, ALD Cerio, P Sarobe, M Ruiz, I Melero, J Prieto, ... European journal of immunology 31 (6), 1780-1789, 2001 | 101 | 2001 |
| Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus L Arribillaga, ALD de Cerio, P Sarobe, N Casares, M Gorraiz, A Vales, ... Vaccine 21 (3-4), 202-210, 2002 | 94 | 2002 |
| In vitro and in vivo down-regulation of regulatory T cell activity with a peptide inhibitor of TGF-β1 L Gil-Guerrero, J Dotor, IL Huibregtse, N Casares, AB López-Vázquez, ... The Journal of Immunology 181 (1), 126-135, 2008 | 90 | 2008 |
